A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Endocrine Tumors of the Gastrointestinal Tract.

NCT00448136 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: bevacizumab [Avastin]
DRUG: 5 FU
DRUG: Streptozotocin
DRUG: Xeloda

Sponsor

Hoffmann-La Roche